Amgen Q4 EPS $4.71 Beats $4.62 Estimate, Sales $8.20B Beat $8.13B Estimate
Portfolio Pulse from Benzinga Newsdesk
Amgen (NASDAQ:AMGN) reported Q4 earnings of $4.71 per share, surpassing the $4.62 estimate, marking a 15.16% year-over-year increase. Quarterly sales reached $8.20 billion, exceeding the $8.13 billion estimate, a 19.84% increase from the previous year.
February 06, 2024 | 9:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen reported a significant beat on both earnings and sales estimates for Q4, with a notable year-over-year growth in earnings and sales.
Beating both earnings and sales estimates typically leads to positive investor sentiment and can result in a short-term stock price increase. The substantial year-over-year growth in earnings and sales further strengthens the case for a positive impact on Amgen's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100